Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
General Drug Use-Results Survey of Onoact for refractory life-threatening ventricular arrhythmias
jRCT1080225340Completed
- Sponsor
- Ono Pharmaceutical
- Start
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of pafuramidine in ventricular fibrillation (VF) and ventricular tachycardia (VT), sponsored by Ono Pharmaceutical. Started Aug 2020; status: completed.
02
Drugs
pafuramidine
03
Conditions
ventricular fibrillation (VF)ventricular tachycardia (VT)
Beyond the preview
Go deeper on jRCT1080225340.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080225340.